Bioxytran (BIXT) FCF Margin Growth (3y) (2013 - 2018)
Bioxytran (BIXT) FCF Margin Growth (3y) (2013 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn | -5,426.00 |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 9,545.00 |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn | 4,612.00 |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn | 1,850.00 |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 14,060.00 |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | -3,088.00 |
| 10 | Bioxytran | 2.52 Mn | 2.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 1,287.00 |
| Mar 31, 2018 | 490.00 |
| Dec 31, 2017 | -14,250.00 |
| Sep 30, 2017 | 87.00 |
| Jun 30, 2017 | 11,418.00 |
| Mar 31, 2017 | -12,684.00 |
| Dec 31, 2016 | -1,608.00 |
| Sep 30, 2016 | 26,325.00 |
| Jun 30, 2016 | -416.00 |
| Mar 31, 2016 | -6,572.00 |
| Dec 31, 2015 | 989.00 |
| Sep 30, 2015 | 63,423.00 |
| Jun 30, 2015 | -1,336.00 |
| Mar 31, 2015 | 425.00 |
| Dec 31, 2014 | 96,345.00 |
| Sep 30, 2014 | 61,030.00 |
| Jun 30, 2014 | 20,756.00 |
| Mar 31, 2014 | 34,034.00 |
| Dec 31, 2013 | 25,273.00 |
| Sep 30, 2013 | 225,045.00 |